Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle.

PTH-related protein (PTHrP) is produced in vascular smooth muscle, where it is postulated to exert vasorelaxant properties by activation of the PTH/PTHrP type 1 receptor. As a model for studying the actions of locally produced PTHrP in vascular smooth muscle in vivo, we developed transgenic mice that overexpress the PTH/PTHrP receptor (PTHrP-R) in smooth muscle. Oocyte injection with a SMP8-PTHrP-R fusion construct yielded six founder mice. F1 offspring were viable and demonstrated selective overexpression of the SMP8-PTHP-R messenger RNA in smooth muscle-rich tissues. Baseline blood pressure measured in conscious mice by tail sphygmomanometry was significantly lower in the receptor-overexpressing mice than that in controls (117 +/- 4 vs. 133 +/- 3 mm Hg; P < 0.05). In anesthetized animals, iv infusion of PTHrP-(1-34)NH2 caused a significantly greater reduction in blood pressure and total peripheral resistance in transgenic mice than in control animals. Vascular contractility was studied in paired, isometrically mounted aortas from 9-week-old transgenic and wild-type mice. The force of contraction in response to phenlyephrine was not significantly different between transgenic and wild-type mice. However, PTHrP-(1-34) NH2 relaxed aortic vessel preparations from transgenic mice to a greater extent than in controls (77.1 +/- 3% vs. 38.4 +/- 4%; P < 0.001). To determine the impact of overexpression of PTH/PTHrP type 1 receptor and its ligand on the development of the cardiovascular system, double transgenic mice were created by crossing SMP8-PTHrP-R transgenic mice with mice overexpressing PTHrP (SMP8-PTHrP). Double transgenic mice died around day E9 with abnormalities in the developing heart. In conclusion, overexpression of PTH/PTHrP type 1 receptor in vascular smooth muscle of transgenic mice reduces blood pressure, probably through sustained activation of the receptor by endogenous ligand. The cardiovascular defects observed in mice overexpressing both PTHrP and its receptor suggest that PTHrP may play a role in the normal development of the cardiovascular system.

[1]  T. Clemens,et al.  Vasorelaxant properties of parathyroid hormone-related protein in the mouse: evidence for endothelium involvement independent of nitric oxide formation. , 1999, Endocrinology.

[2]  T. Clemens,et al.  Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. , 1999, Endocrinology.

[3]  A. F. Stewart,et al.  Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Doetschman,et al.  Defective Endothelium-dependent Relaxation of Vascular Smooth Muscle and Endothelial Cell Ca2+ Signaling in Mice Lacking Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 3* , 1997, The Journal of Biological Chemistry.

[5]  Y. Nikiforov,et al.  Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. , 1997, The Journal of clinical investigation.

[6]  T. Bonner,et al.  Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. , 1996, Endocrinology.

[7]  B. Lanske,et al.  PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth , 1996, Science.

[8]  T. Clemens,et al.  Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. , 1996, Endocrinology.

[9]  T. Usdin,et al.  The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor. , 1996, Endocrinology.

[10]  J. Wysolmerski,et al.  Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. , 1995, Development.

[11]  K. McHugh.  Molecular analysis of smooth muscle development in the mouse , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[12]  T. Bonner,et al.  Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 Receptor (*) , 1995, The Journal of Biological Chemistry.

[13]  T. Kenakin,et al.  Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor , 1995, Nature.

[14]  T. Clemens,et al.  Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP. , 1994, Endocrinology.

[15]  L. Deftos,et al.  Parathyroid hormone-related protein in the cardiovascular system. , 1994, Endocrinology.

[16]  J. Boonstra,et al.  Expression pattern of parathyroid hormone/parathyroid hormone related peptide receptor mRNA in mouse postimplantation embryos indicates involvement in multiple developmental processes , 1994, Mechanisms of Development.

[17]  S. Yamashita,et al.  Expression of parathyroid hormone-related peptide in relation to perturbations of gastric motility in the rat. , 1994, Endocrinology.

[18]  E. Fuchs,et al.  Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J Glowacki,et al.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. , 1994, Genes & development.

[20]  T. Clemens,et al.  Effects of N-terminal, midregion, and C-terminal parathyroid hormone-related peptides on adenosine 3',5'-monophosphate and cytoplasmic free calcium in rat aortic smooth muscle cells and UMR-106 osteoblast-like cells. , 1993, Endocrinology.

[21]  A. Broadus,et al.  Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus. , 1992, The Journal of biological chemistry.

[22]  M. Thiede,et al.  Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Freeman,et al.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Clemens,et al.  Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. , 1991, The Journal of clinical investigation.

[25]  A. Broadus,et al.  Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Lessard,et al.  Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma- enteric isoform in differentiating striated myocytes , 1989, The Journal of cell biology.

[27]  J. Thompson,et al.  Parathyroid hormone as a smooth muscle relaxant. , 1989, Endocrine reviews.

[28]  E. Chen,et al.  A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. , 1987, Science.

[29]  J. Orloff,et al.  Defining the roles of parathyroid hormone-related protein in normal physiology. , 1996, Physiological reviews.

[30]  E. Brown,et al.  Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions. , 1996, Bailliere's clinical endocrinology and metabolism.